Latest Breaking News On - Executive chairman ian miscampbell - Page 1 : comparemela.com

Proprietary Lateral CAR Platform achieved pre-clinical proof-of-concept data demonstrating prolonged disease-free survival compared to other CAR T-cell products.Lead programme, LEU011 has completed

United statesUnited kingdomCity ofEast sussexIan miscampbellDennis riedlPrnewswire leucid bioMark dochertyArindam mitraBelinda carlsenMarc daviesJohn maherLeucid bioSenior leadership teamKing college londonSeasoned life sciences